Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap.
Designed to improve ablation outcomes and procedural efficiencies, the newly updated vMap software integrates additional automation and advanced visualisation features, the company said in a press release.
vMap is the a US Food and Drug Administration (FDA)-cleared, AI-based non-invasive solution that unlocks the data contained in a standard 12-lead electrocardiogram (ECG), enabling physicians to rapidly and accurately locate arrhythmia source locations. The software upgrades are designed to improve the accuracy, visualisation, and efficiency of arrhythmia analysis and interpretation.
The updates include Beat Assist software that recommends and auto-selects arrhythmic beats of interest that may indicate the source location of an arrhythmia, an upgraded heart model intended to provide a highly realistic and more detailed representation of the heart, and automated ECG baseline correction that removes baseline noise from input ECG signals.
“The vMap software upgrades and enhanced visualisation capabilities have made a significant impact on my ability to see the arrhythmia source location and plan the EP procedure,” stated Greg Feld (UC San Diego Health, San Diego, USA). “The level of detail and clarity solidify vMap as a cutting-edge solution in arrhythmia care and will empower EPs to navigate the heart with more accuracy and confidence.”
